Company Update Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand
Company Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.
Company Update Please find the disclosure Regarding stock split of the Company. Please find the disclosure Regarding stock split of the Company.
Updates VARVEE GLOBAL LIMITED has informed the Exchange regarding 'Investors Presentation for the Fourth Quarter and year ended March 31, 2026'. VARVEE GLOBAL LIMITED has informed the Exchange regarding 'Investors Presentation for the Fourth Quarter and year ended March 31, 2026'.
Company Update Announcement under Regulation 30 (LODR) - Earnings Call Transcript. Announcement under Regulation 30 (LODR) - Earnings Call Transcript.
Corp Action Board of Directors have considered and recommended final dividend of Rs. 55 per equity share for the financial year 2025-26 subject to the approval of shareholders in the ensuing Annual General Meeting. Board of Directors have considered and recommended final dividend of Rs. 55 per equity share for the financial year 2025-26 subject to the approval of shareholders in the ensuing Annual General Meeting.
Company Update We are pleased to inform that the Company has successfully opened a new strategic Centre at Dwarka New Delhi. We are pleased to inform that the Company has successfully opened a new strategic Centre at Dwarka New Delhi.
Company Update Investor Presentation for the fourth quarter and year end March 31 2026 Investor Presentation for the fourth quarter and year end March 31 2026
Outcome of Board Meeting Asian Hotels (North) Limited has submitted to the Exchange, the Standalone & Consolidated financial results for the quarter and year ended March 31, 2026 along with Auditors' Report and a declaration for unmodified opinion Asian Hotels (North) Limited has submitted to the Exchange, the Standalone & Consolidated financial results for the quarter and year ended March 31, 2026 along with Auditors' Report and a declaration for unmodified opinion
Outcome of Board Meeting Lorenzini Apparels Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Lorenzini Apparels Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
General Updates Pilani Investment and Industries Corporation Limited has informed the Exchange about General Updates- Decision on dividend to be proposed by the Board of Directors has been adjourned for being considered and decided at the adjourned meeting of the Board of Directors to be held on Thursday, 4th June, 2026 and the said decision will accordingly be intimated by the company and disclosures be made accordingly. Pilani Investment and Industries Corporation Limited has informed the Ex
Corp. Action Recommendation of Dividend by Board for the F. Y. 2025-26 Recommendation of Dividend by Board for the F. Y. 2025-26
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."
No credit card required. Connect WhatsApp or Telegram in minutes.